Skip to main content
. 2021 Jun 7;10(6):923. doi: 10.3390/antiox10060923

Figure 2.

Figure 2

Representative curves of thrombin-catalyzed fibrin polymerization and fibrinolysis. ACS: patients with acute coronary syndrome; SCAS: patients with significant carotid artery stenosis; AIS: patients with acute ischemic stroke; control: patients with normal angiogram. Clot degradation was measured at 350 nm after addition of thrombin (12 NIH U/mL), plasminogen (0.15 NIH U/mL), tPA (0.3 µg/mL) and CaCl2 (8 mM).